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The stimulation of resting T cells to an activated state is caused by signals re-
ceived by the cells from their environment. To date, neither the number of signals
required nor their exact nature are precisely known. Thus far, an understanding
of the triggering events indicates that a necessary signal is delivered to the cell by
the crosslinking ofthe antigen-specific receptor by its ligand (reviewed in reference
1). Also, it has become clear that at least one other signal is required for the T cell
to proliferate and become functionally active. Previous evidence has indicated that
the cytokine, IL-1, was able to provide this "second" signal to the T cell (2).
However, it hasrecently been demonstrated that another cytokine, designated IL-
6, also has the ability to provide such a second signal to mitogen-stimulated T cells
(3). This property ofIL-6 was revealed in an assay system that used highly purified
lymph node Tcells. This cell population, devoid ofany detectable APCs, does not
proliferateinvitro in response to mitogen, mitogen plus IL-2, or mitogen plus IL-1
(4). However, whentheseTcells werecultured with mitogen plusIL-6 astrong prolifer-
ative response was observed (3). Thus, by using this unique assay system a novel
pathway for T cell activation involving IL-6 was identified.
In this paper, wedemonstrate the existenceofanothercytokine that has costimula-
tory activity with Con A when added to cultures of highly purified T cells. This
25-kDprotein, designated IL-7, was firstidentified by its ability to support thegrowth
of pre-B cells that were generated in WitteWhitlock bone marrow cultures (5-7).
The cDNA encodingbiologically active murine IL-7 was isolated from abone marrow
stromal cell cDNA library and expressed in COS-7 cells (8). Surprisingly, when the
rIL-7 was tested in the T cell activation assay, it had potent co-stimulatory activity.
Highly purified T cells cultured with Con A plus IL-7 have significantly increased
levels ofIL-2 receptor expression, IL-2 production, and proliferation as has been
reported for IL-6. Thus, IL-7, originally isolated for its potent effect on the growth
of pre-B cells, has additional activating properties for mature, peripheral T cells.
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Materials and Methods
Mice.
￿
BALB/cByJ mice were obtained from TheJackson Laboratory (Bar Harbor, ME).
Female mice used in these studies were between 14 and 18 wk of age.
Assayfor T Cell Activation.
￿
The axillary, inguinal, cervical, and mesenteric lymph nodes
were dissected and a single cell suspension was prepared by teasing the nodes apart and gently
crushing the tissue fragments. After washing, the lymph node cells were either cultured directly,
or further purification of the T cells was performed. Highly purified T cells were prepared
according to the method of Garmen and Raulet (4). The lymph node cells were passed over
a nylon wool column, treated with anti-I-Ad mAb plus complement and passed over nylon
wool a second time. These cells were >99% T cells with no contaminating macrophages or
B cells detectable. These T cells were cultured in 96-well flat-bottomed microtiter plates (2
x 10, purified T cells/well) or in 24-well plates at a density of 2 x 106/well. They were cul-
tured in RPMI 1640 plus 5% FCS, sodium pyruvate, and nonessential amino acids. After
3 d ofculture [3H]TdR (0.51uCi/well, sp act 20 Ci/mM) was added for the last 6-8 h of cul-
ture. The cultures were harvested with an automated sample harvester and the incorporated
[3H]TdR determined by liquid scintillation spectrometry.
Cytokines.
￿
Murine rIL-7 was produced by transfection ofCOS-7 monkey kidney cells with
the expression plasmid pDC201 containing the IL-7 cDNA insert 1046B as described (8).
The supernatant had a biological activity of6 x 104 U/ml in the pre-B cell assay. rIL-7 was
purified from the transfected COS-7 cell supernatants as previously described (5) and had
a similar biological activity (4 x 106 U/Wg protein) as did natural material purified from the
supernatant of the IxNA6 bone marrow stromal cell line. In addition, H2-N terminal amino
acid sequence of the purified recombinant-derived IL-7 was identical to that from the purified
natural material.
cDNA clones encoding human and murine IL-6 were isolated from libraries constructed
from human peripheral blood monocytes and a murine T helper cell line (clone 7B9) mRNA.
In each case the libraries were screened with oligonucleotide probes derived from the pub-
lished gene sequences (9, 10). The cDNA clones were inserted into the expression vector pDC201
(8) and transfected into COS-7 cells to produce rIL-6. The COS-7 cell supernatants trans-
fected with the human and murine IL-6 genes had biological activities of 7 x 105 U/ml and
3 x 106 U/ml respectively, in the T cell activating assay. In addition, COS-7 cell superna-
tants containing human IL-6 also induced Ig secretion by LESS cells (3 x 105 U/ml of bio-
logical activity).
Murine and human IL-2 and human IL-1(3 were produced and purified in house as previ-
ously described (11-13).
Antibodies.
￿
Ascites fluid from the MKD6 cell line was used as a source of monoclonal
anti-I-Ad in the antibody plus complement treatment of the lymph node T cells (14). Cul-
ture supernatants of the 83-12-5 cell line was used as a source of anti-Lyt-2.2 mAb (courtesy
of Dr. J. Bluestone, University ofChicago); supernatant from the GK1.5 cell line as a source
ofanti-L3T4 mAb (15) and supernatant from the 7D4 cell line as a source ofanti-IL-2 receptor
mAb (16). For immunofluorescent staining, FITC-conjugated anti-rat K chain mAb (Becton-
Dickinson, Mountain View, CA) was used as a second step. The anti-murine IL-2 mAb,
S4B6, was a kind gift of Dr. T. Mosman (DNAX, Palo Alto, CA) (17) to S. G. Reed.
Rabbit antibody to murine IL-6 was produced in rabbits by a series of four intravenous
injections of IL-6 encapsulated in liposomes. The IgG fraction of this antisera was purified
by binding to protein A. The antibody was able to inhibit the IL-6-mediated proliferation
ofthe IL-6-dependent plasmacytoma cell line T1165 (Nordan, R. P., submitted for publication).
Immunofuorescent Staining and Flow Cytometry.
￿
For antibody binding, 106 cells were in-
cubated with saturating concentrations ofantibody for 30 min at 4°C. After each incubation
the cells were washed with PBS containing 0.1% BSA and 0.1% NaN3. Samples were ana-
lyzed on an EPIC-C flow cytometer (Coulter Electronics, Hialeah, FL) using an argon laser
that emitted visible light at 488 nm and 300 mW constant power. Data were collected on
104 viable cells. For single-color analysis, cells incubated with the FITC-conjugated second
antibody alone were analyzed to determine background fluorescence levels.
Preparation of Purified CD4' or CD8' T Cells.
￿
CD4' lymph node T cells were prepared
by passing whole lymph node cells over nylon wool and treating the nylon nonadherent frac-MORRISSEY ET AL.
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tions with anti-I-Ad mAb plus complement as usual. The cells were then treated with anti-
Lyt-2.2mAbpluscomplement andpassed overasecond nylonwool column.Thesecellswere
>98% CD4' as assessed by immunofluorescent staining and flow cytometry analysis.
CD8' cells were prepared by passing whole lymph node cells over nylon wool followed
bytreatment ofthe nonadherent fraction with anti-I-Ad mAb plus complement. These cells
were treatedwith anti-L3T4mAb(GK1.5) plus complement, then positively selectedon anti-
Lyt-2.2-coated plastic dishes (18). These cells were routinely >99% CD8', as assessed by
immunofluorescent staining and flow cytometry analysis.
Results
IL-7 InducesProliferation ofHighly Purified TCells Cultured with Con A.
￿
It has been
previously shown that highly purified T cells do not proliferate in response to Con
A or Con A plus IL-2, but that an additional signal that is not IL-1 is required (4).
Recently it has been demonstrated that this second signal, previously known as T-
activating factor (TAF), could be provided by the lymphokine IL-6 (3). Thus, in
this system, purifiedTcells cultured withConA alonewere not induced toproliferate
whereas cells cultured with ConA plus IL-6 proliferated strongly. In ourassessment
ofthe biological activity ofrecombinant-derived IL-7 we have foundthat itwill also
induce the proliferation ofhighly purified T cells cultured with Con A. In Table
1, a representative experiment showing the effect of both rIL-6 and rIL-7 on the
proliferative response of highly purified BALB/c T cells is shown. In this experi-
ment, the T cells responded minimally to Con A alone. This response was slightly
increased by the addition of 50 ng/ml of murine rIL-2. This amount of IL-2 is
saturating, as higher responses are not seen with greater amounts ofIL-2 (data not
shown). Also it can be seen that cells cultured with human rIL-6 in the absence
ofConA didnot respond, but inthe presence ofConA, significant levels ofprolifer-
ationwere seen. Similarly, culturingthecells with murine rIL-7 alone didnot cause
proliferation but in the presence ofCon A a strong proliferative response was ob
served.
￿
It should be noted that culture supernatants from COS cells transfected
with an irrevelant plasmid had no activity in this assay (data not shown). In Fig.
1, the activity of the purified murine rIL-7.in the Tcell activation assay is shown.
Here it can be seen that purified IL-7 has potent activating capability when added
to purifiedT cells plus ConA. In this assay, the half-maximal stimulation occurred
with 0.3 ng/ml ofprotein. Over a number of experiments, this value ranged from
0.07 to 0.4ng/ml ofIL-7. In the pre-B cell growth assay, the half-maximal stimula-
tion occurred at 0.03 ng/ml (data not shown). Thus, these results demonstrate that
recombinant-derived IL-7, acytokine originally isolated because ofitsabilitytosupport
the growth ofpre-B cells, also has strong co-stimulatory activity for mature T cells.
Both CD4' and CD8' Cells Respondto Con A Plus IL-7
￿
Previously, there has been
considerable evidence produced that the activation requirements for CD4' and
CD8' T cells are fundamentally different (19, 20). For instance, it has been pro-
posed that CD8' cells required an additional signal in orderto generate functional
cytotoxic cells that is not required for the generation offunctional helper cells (21).
Therefore, it was of interest to determine the responsiveness of purified CD4' and
CD8' T cellsto Con A plus IL-7. CD8' cells were purified from nylon nonadherent
T cells by a combination ofnegative (anti-L3T4 plus complement treatment) and
positive selection(adherence toanti-Lyt-2-coatedplates). Cellsprepared inthismanner
had no detectable CD4' T cells. CD4' cells were prepared from nylon nonadherent710
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TABLE I
Response of Purified T Cells to Con A Plus IL-7 or IL-6
Cells (2x 105/well) were cultured for 72 h with the indicated additions. The con-
centration of Con A was 2 .5 14g/ml; the concentration of IL-2 was 50 ng/ml.
IL-6 and IL-7 as COS cell supernatants were added at the dilutions indicated.
The data are the arithmetic mean of quadruplicate cultures.
lymphnodecells by negative selection with anti-Lyt-2.2 mAb plus complement treat-
ment. These cells were then passed over a second nylon wool column . This popula-
tion of cells was routinely >98% CD4' T cells. These cell populations were then
cultured with Con A or Con A plus IL-6 or IL-7. The results ofa representative
experiment are shown in Table II. Here it can be seen that both the CD4+ and
CD8' T cells responded minimally to Con A alone, but the cells cultured with Con
Aand either IL-6 or IL-7 proliferated strongly, Analysis ofthe cell populations at
the end ofculture by immunofluorescent staining and flow cytometry showed that
there was <2% contaminating cells. In addition, other cultures were subjected to
two color-flow cytometry to determine the cell cycle status and proportion ofeach
(CD4+ or CD8+) cell population. The results of this analysis (data not shown)
confirmed the results obtained in the proliferative assay in that both CD4+ and
CD8+ T cell subpopulations proliferated in response to Con A plus IL-7 and IL-6.
Thus, both IL-6 and IL-7 have co-stimulatory activity for the CD4+ and CD8'
subpopulations of T cells.
FIGURE 1.
￿
Co-stimulatory activity of purified murine
rIL-7 for purified peripheral T cells. Dilutions ofpurified
rIL-7 were added to cultures containing highly purified
T cells plus Con A (2,5 p.g/ml). [3H]TdR uptake was
assessed in the final 6 h of a 72-h culture. Response of
the cells to ConA in the absence of IL-7 was 1,083 cpm.
Response of cells alone was 486 cpm. The data are the
average of triplicate values. The SEM was <5% of the
mean and is omitted for convenience.
Cells cultured with: Dilution of cytokine [3H]TdR uptake
cpm (SEM) x 10-3
Con A 2 (1.2)
No additions 0.52 (.12)
Con A + IL-2 4 .3 (0.9)
Con A + IL-7 1:10 51 .9 (9.3)
1 :500 37 .6 (3.2)
1 :2,500 6.3 (1 .5)
IL-7 1 :10 3.6 (1 .1)
Con A + IL-6 1:10 31 .6 (3.6)
1 :500 18.3 (0.6)
1:2,500 5.0 (1 .8)
IL-6 1 :10 2.7 (1 .4)Con A + 10
Con A
media
TABLE II
Response of Purled L3T4+ or Lyt-2+ T Cells to Con A
Plus IL-6 or IL-7
Purified CD4* or CD8* T Cells (105 cells/well) were cultured for 72 h. [3H]TdR
was added for the last 6 h o£ culture. The data are the mean (SEM) of quad-
ruplicate values. IL-6 and IL-7 were COS cell supernatants and were at a final
concentration of 10% (vol/vol).
IL-7 Induces IL-2 Receptors andIL-2 Production by Resting TCells.
￿
It has previously
been demonstrated that cytokines withco-stimulatory activity forTcells (e.g., IL-1
and IL-6) act to induce the expression of IL-2 receptors and IL-2 production as
well as proliferation (2, 3). We investigated whether IL-7 also induced these func-
tional changes in the stimulated T cell population.
Highly purified T cells (2 x 106/well) were cultured in 24 well plates with either
no additives, Con Aalone, or Con Aplus IL-7. At 24 h, 0.1 ml was removed from
the cultures and assayed forIL-2 activity by the induction ofproliferationofCTLL
cells in the presence of 11BIl mAb in orderto neutralize any IL-4 activity (22). The
results shown in Fig. 2 clearly demonstrate that incubation of the highly purified
T cells with ConA plus IL-7 caused asubstantial increasein thelevelofIL-2 produc-
tion. At 48 h, thecells in these cultures were harvested and stained withthe anti-IL-
2 receptor antibody 7D4 plus fluoresceinated second step, and analyzed by flow
microfluorimetry. As can be seen in Fig. 3, cells incubated with Con A alone ex-
pressed low levels of the IL-2 receptor (17% of the cells stained positively with a
mean linear fluorescence of 15). Cells incubatedwith Con A plus IL-7 had highlevels
ofIL-2 receptor expression (67% ofthe cells stained positively with a mean linear
cpm x 10 '3
MORRISSEY ET AL.
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FIGURE 2.
￿
IL-2 activity ofculture
supernatants from T cells stimu-
lated with Con A plus IL-7.
Purified lymph node T cells were
cultured in 24-well plates (2 x 106
cells/well in 2 ml) with 2.5 Wg/ml
Con A and 50 ng/ml purified rIL-7.
After 24 h, an aliquot ofculture SN
was removed and assayed for IL-2
activity by its ability to stimulate
the proliferation ofCTLL cells. The
anti-IL-4 mAb 11BIl was added to
the cultures to neutralize any IL-4
activity. The data are the arithmetic
mean plus SEM of quadruplicate
cultures. The culture supernatant
was tested at a 1:4 dilution.
T cell
subpopulation Con A
Proliferative response to:
Con A + IL-6 Con A + IL-7
cpm (SEM) x 10-3
CD4+ 3 .2 (.56) 31.8 (1 .7) 42.2 (3.0)
CD8+ 1.2 ( .74) 29.5 (2 .1) 36.1 (2.4)712
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FIGURE 3.
￿
Expression of IL-2-R by
purified T cells cultured with Con A
plus IL-7. Purified lymph node T cells
were cultured for 48 h in 24-well plates
(2 x 106 cells/well in 2 ml) with 2 .5
Wg/ml Con A and 50 ng/ml purified
rIL-7. The cells were harvested,
stained, and analyzed as described in
Fluorescence Intensity
￿
Materials and Methods.
fluorescence of 83). Thus, the co-stimulatory activity ofIL-7 appears to function
by the induction of IL-2 receptor expression and IL-2 production. In our hands
IL-6 also stimulates IL-2 production and IL-2 receptor expression (datanot shown).
Additionally, IL-7 was as potent as IL-6 in the induction ofboth ofthese functional
changes.
TCellProliferation Inducedby IL-6 andIL-7 isDependent on IL-2 Production.
￿
T cells
cultured withConAplus IL-6or IL-7 are induced toproliferateand to secrete IL-2.
It was ofinterest todetermine ifIL-2 was necessaryforproliferation orifthe signals
provided by Con A plus IL-6 or IL-7 were sufficient to drive proliferation. To ap-
proach this question, the anti-murine IL-2 mAb S4B6 was added to the cultures
at their initiation to determine ifthe neutralization ofthe IL-2 produced would in-
hibit the proliferation. The results of such an experiment are shown in Table III.
Here it can be seen that the addition of S4116 to the cultures of T cells plus IL-6
or IL-7 totally inhibited the proliferative response. In addition, the response was
restored by the addition ofhuman IL-2 to the cultures. Since S4B6 does not bind
orneutralize human IL-2, this result demonstrates that the inhibition ofprolifera-
tion isnot due to nonspecific effects but is due to the neutralization ofIL-2 activity
in the cultures by the mAb. Thus, these results show that the proliferative response
TABLE III
Effect of Anti-IL-2 mAb on the Response of Purified T Cells
to Con A plus IL-7 or IL-6
Purified T cells (2 x 105/well) were cultured for 72 h with the indicated addi-
tives. IL-6 and IL-7 as COS cell supernatants were added at 10% (vol/vol) final
dilutions. S4B6 mAb was ascites fluid. Human rIL-2 was used at a concentra-
tion of 25 ng/ml.
Purified T cells
cultured with Con A plus: [3H]TdR uptake
cpm (SEM) x 10-3
No additions 4 .6 (0.8)
IL-7 25 .8 (1.1)
IL-7 + S4B6 (1 :400) 4.0 (1.0)
(1 :1,000) 5 .2 (0.2)
IL-7 + S4B6 (1:400) + hu IL-2 64.5 (2.7)
IL-6 21 .6 (3.1)
IL-6 + S4136 (1 :400) 3 .6 (1.2)
(1 :1,000) 3 .5 (0.6)
IL-6 + S4B6 (1 :400) + hu IL-2 57 .5 (3.2)MORRISSEY ET AL.
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of highly purified T cells to Con A plus IL-6 or IL-7 is dependenton the production
of IL-2 .
The Co-stimulatory Activity of IL-7 Is Not Due to the Induction ofIL-6.
￿
The action
of IL-7 in the T cell activation assay could possibly be due to the induction of IL-6
production by theT cells. Thus, IL-7 would not act directly as a comitogen for the
T cells, but as an inducer of IL-6 production. To address this possibility, a neu-
tralizinganti-murine IL-6 antibody was added to cultures ofhighly purified T cells
with Con A plus IL-6 or IL-7 . IfIL-7 acted to induce the production of IL-6 which
was the co-mitogen, then the anti-IL-6 antibody should inhibit the IL-7-mediated
response. The results of this experiment are shown in Table IV. Here it can be seen
that the protein A-purified rabbit anti-murine IL-6 inhibited the response of the
T cells stimulated with Con A plus IL-6 at all three doses of IL-6 used. In fact, at
the highest concentration of antibody (1 wg/ml), the inhibition was >90%. In con-
trast, the response oftheTcellsto IL-7 wasnot significantly reducedby theaddition
of the antibody. It should be noted that the addition of an equivalent amount of
purified rabbit anti-human IL-1 had no effect on the response of the T cells to the
Con A plus IL-6 or IL-7 . Thus, these results strongly suggest that action of IL-7
in the T cell activation assay is not via the induction of IL-6, but that IL-7 can act
directly as a comitogen for T cells.
Discussion
The signals required to induce a proliferative response in T cells are complex.
It is clear that a single stimulus is not sufficient, but that a series of signals must
be encountered by the cell before activation occurs. In this report we have found
that IL-7, a molecule discovered because of its potent activity on pre-B cells, also
has costimulatory activity on purified T cells. This activity was revealed using the
assay system of Raulet and Garmen (4) in which T cells are highly purified by a
TABLE IV
Effect of Anti-IL-6 Antibody on the Proliferative Response of Cells to Con A plus
IL-6 or Con A plus IL-7
Highly purified T cells were cultured with Con A and the indicated amount of murine IL-6
or IL-7 . The rabbit anti-mouse IL-6 was added in the indicated amounts at the initiation of
culture. [3H]TdR uptake was measured on day 3. The response ofthe cells plus Con A only
was 2,396 cpm.
Antibody
concentration (1/1,000)
Proliferative Response
IL-6
(1/5,000)
to Con A Plus:
(1/25,000)
IL-7
25 ng/ml
lag/ml cpm x 10-3 cpm x 103
0 119 .7 97.5 86.3 133 .3
1 .0 16 .9 8.2 10.4 135 .4
0.5 45 .9 15.1 12.9 138.6
0.25 92 .9 45.4 26.5 129.7
0.12 94.8 67 .7 38.6 132.5
0.06 105 .8 75 .4 48.4 137 .7
0.03 110.3 83.8 68.8 133 .5
0.015 118 .1 93.7 81 .3 135 .871 4 ,
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combination of two passages through nylon wool and treatment with anti-la plus
complement before culture. These manipulations result in a cell population that
is highly enriched for T cells and functionally devoid of APCs. Cells prepared in
this manner exhibit unusual requirements for triggeringin vitro in that incubation
with mitogen plus IL-2 does not result in significant cellular activation. Originally,
Garman and Raulet (4) described a factor in the culture supernatant of Con A-stimu-
lated murine spleen cells and certain T cell hybridomas that has co-stimulatory ac-
tivity for these highly purified T cells. Recently, this activity has been attributed
to IL-6 (3) . Here we find that IL-7 also is active in this assay system.
In this report we have also provided evidence that IL-7 exerts its co-stimulatory
effect by inducing the expression of IL-2 receptors and stimulating the production
of IL-2. Thus, cultures of T cells with Con A plus IL-7 had significantly greater
levels ofIL-2 in the culture supernatant than cells incubated with Con A alone. Also
T cells stimulated with Con A plus IL-7 had a greater percentage of cells expressing
the IL-2 receptor and the mean level of receptor expression was also greater than
that observed by the cells incubated with Con A alone. The ability of the anti-IL-2
mAb to inhibit the proliferation of the T cells incubated with Con A plus IL-7 fur-
ther demonstrates that the production of IL-2 is necessary for the proliferative re-
sponse. Thus, it appears that IL-7, as well as IL-6 (3), exerts co-stimulatory activity
by inducing the production of IL-2 and the expression of IL-2 receptors.
It is possible that the activity of IL-7 in this assay system was to induce the production
of IL-6 that then was the actual TAF (inducing IL-2 production and IL-2 receptor
expression). However, the inability of the anti-IL-6 antibody to neutralize the IL-7-in-
duced T cell proliferation strongly suggests that the IL-7, in of itself, has T cell ac-
tivating properties.
It is not clear if the IL-6 and IL-7 induce the same or different subpopulations
of T cells. Cell cycle analysis of the T cells stimulated with Con A plus IL-6 and
IL-7 over many experiments has revealed that from 21 to 43% of the T cells were
induced to cycle (data not shown). Cultures of T cells stimulated with Con A plus
IL-6 and IL-7 have shown the effects of both cytokines to be synergistic and not
additive, suggesting that at least some T cells respond to both factors. We are cur-
rently using limiting dilution analysis ofT cells responding to Con A plus IL-6 and/or
IL-7 to approach this question.
It is also apparent that these molecules are functionally plieotropic. For instance,
IL-6 also has potent activity on B cells, causing the induction of Ig synthesis and
supporting the growth of B cell hybridomas and plasmacytoma (9, 23). IL-7 was
also orignally cloned because of its potent growth factor activity on pre-B cells (8).
Thus both these factors have significant growth and differentiative capabilities for
B cells. Of additional interest is the observation that IL-6 augmented the prolifera-
tion ofPHA-activated human thymocytes (24), thereby suggesting that this cytokine
may be involved in T cell differentiation. We have found that IL-7 also has comito-
genic activity for thymocytes (Conlon, P. J., submitted for publication). Indeed IL-7
has co-stimulatory activity for the least mature CD4 - /CD8 - thymocyte popula-
tion in both adult and fetal thymus. Thus, this cytokine can augment the prolifera-
tive response of immature as well as mature T cells. The range ofactivities associated
with IL-7 indicates that it may play an important role in the production and func-
tion of B cells and T cells.MORRISSEY ET AL.
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Summary
The activation of highly purified murine peripheral T cells in vitro by Con A is
dependent on a co-stimulatory signal that is not IL-1 or IL-2. Previous evidence
has demonstrated that the recently defined lymphokine IL-6 could provide costimula-
tory activity for purified T cells cultured with Con A. In this report we demonstrate
that IL-7 also has potent co-stimulatory activity for purified murine T cells, as well
as its previously described ability to support the growth of pre-B cells in Witte-Whitlock
cultures. When rIL-7 was added to cultures of purified T cells together with Con
A, it induced the expression of IL-2 receptors, IL-2 production, and consequently
proliferation. In addition, IL-7 exhibited the same magnitude of activity in this assay
as IL-6. Also, anti-IL-6 antibody which inhibited the IL-6-induced response had
no effect on the IL-7 response. Thus, IL-7 does not act by inducing IL-6. These
results demonstrate that IL-7, a potent growth stimulus for pre-B cells, also has a
role in T cell activation.
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